Fidelity Investments
LUNG icon

Fidelity Investments’s Pulmonx LUNG Stock Holding History

Fidelity Investments’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$62.2K Sell
48,222
-26,980
-36% -$44.6K ﹤0.01% 4013
2025
Q4 		$166K Sell
75,202
-2,099,156
-97% -$3.95M ﹤0.01% 3520
2025
Q3 		$3.52M Sell
2,174,358
-2,087,010
-49% -$4.37M ﹤0.01% 2346
2025
Q2 		$11M Sell
4,261,368
-1,156,888
-21% -$4.56M ﹤0.01% 1896
2025
Q1 		$36.5M Sell
5,418,256
-504,926
-9% -$3.58M ﹤0.01% 1477
2024
Q4 		$40.2M Buy
5,923,182
+50,300
+0.9% +$331K ﹤0.01% 1466
2024
Q3 		$48.7M Buy
5,872,882
+591,859
+11% +$4.28M ﹤0.01% 1383
2024
Q2 		$33.5M Buy
5,281,023
+427,088
+9% +$3.28M ﹤0.01% 1469
2024
Q1 		$45M Buy
4,853,935
+1,544,434
+47% +$18.1M ﹤0.01% 1366
2023
Q4 		$42.2M Buy
3,309,501
+1,279,666
+63% +$13.3M ﹤0.01% 1356
2023
Q3 		$21M Buy
2,029,835
+401,830
+25% +$4.65M ﹤0.01% 1569
2023
Q2 		$21.3M Buy
1,628,005
+665,507
+69% +$8.14M ﹤0.01% 1609
2023
Q1 		$10.8M Buy
962,498
+927,223
+2,629% +$9.15M ﹤0.01% 1846
2022
Q4 		$297K Sell
35,275
-6,466
-15% -$61.5K ﹤0.01% 2884
2022
Q3 		$695K Buy
41,741
+564
+1% +$10.4K ﹤0.01% 2689
2022
Q2 		$606K Sell
41,177
-281
-0.7% -$5.79K ﹤0.01% 2789
2022
Q1 		$1.03M Sell
41,458
-439,796
-91% -$11.4M ﹤0.01% 2784
2021
Q4 		$15.4M Sell
481,254
-3,531
-0.7% -$129K ﹤0.01% 1938
2021
Q3 		$17.4M Buy
484,785
+203,217
+72% +$8M ﹤0.01% 1899
2021
Q2 		$12.4M Sell
281,568
-198,292
-41% -$8.63M ﹤0.01% 2021
2021
Q1 		$21.9M Sell
479,860
-95,104
-17% -$5.45M ﹤0.01% 1761
2020
Q4 		$39.7M Buy
+574,964
New +$28.2M ﹤0.01% 1413

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments's LUNG Position: Q1 2026 in Review

Fidelity Investments reduced its Pulmonx (LUNG) stake by 36% in Q1 2026, selling an estimated $44.6K and leaving 48,222 shares worth $62.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4013.

Fidelity Investments first reported a position in LUNG in Q4 2020 and has held it in 22 quarters since. The position peaked at $48.7M in Q3 2024. 113 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

  • Fidelity Investments held 48,222 shares of Pulmonx worth $62.2K as of Q1 2026.
  • Fidelity Investments sold 26,980 Pulmonx shares in Q1 2026, an estimated $44.6K.
  • Pulmonx made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4013 holding.
  • Fidelity Investments first reported a position in Pulmonx in Q4 2020 and has held it in 22 quarters since.
  • Fidelity Investments's Pulmonx position peaked at $48.7M in Q3 2024.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.